Philip K. Yachmetz, SVP, General Counsel at SAVIENT PHARMACEUTICALS INC (SVNT), sold 5,778 shares at $13.80 ($80K) on 2010-02-16, disclosed to the SEC on 2010-02-17.
Scheduled sale ($80k) by SVP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.79 | 3,307 | $46K | 57.2% |
| 2 | $13.80 | 2,471 | $34K | 42.8% |
| Total | $13.79 avg | 5,778 | $80K | 100% |
| Filing → |
| SVNT | SELL | 2013-01-16 | $1K | — | Filing → |
| SVNT | SELL | 2012-02-23 | $7K | — | Filing → |
| SVNT | BUY | 2011-09-16 | $29K | — | Filing → |